
Sakar Healthcare Ltd. (SAKAR) Share Price Rises 9.11% Today
Updated: 1 Sept 2026 • 12:26 pm
Posted by:

Sakar Healthcare Ltd. Share Price rose to Rs 942, up Rs 78.65 or 9.11% in the session. The stock opened at Rs 866.3, hit a high of Rs 949, a low of Rs 864, and recorded turnover of Rs 16.62 crore. The move has brought the stock into focus, but the supplied data does not confirm a company-specific trigger.
Sakar Healthcare Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 942 |
| Previous Close | Rs 863.35 |
| Today's Move | Rs 78.65 (+9.11%) |
| Open | Rs 866.3 |
| High | Rs 949 |
| Low | Rs 864 |
| Turnover | Rs 16.62 crore |
| Market Capitalisation | Rs 1,948.42 crore |
| Market Cap Category | Small Cap |
Sakar Healthcare Ltd. (SAKAR) rose to Rs 942 from the previous close of Rs 863.35, a move of Rs 78.65 or 9.11%. The stock opened at Rs 866.3, reached a high of Rs 949, recorded a low of Rs 864.
The stock advanced from the previous close of Rs 863.35 to Rs 942. Opening at Rs 866.3 and staying above the previous close through the session, it traded in a relatively wide intraday band of Rs 864 to Rs 949. With the last quoted price close to the day’s high, the session reflected sustained buying interest rather than only a brief spike.
Turnover stood at Rs 16.62 crore, which shows meaningful participation for the day. Based on the verified data alone, the clearest conclusion is that SAKAR saw a strong same-day rise, while the reason for the move is not established in the available dataset.
Sakar Healthcare Ltd. (SAKAR) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,948.42 crore |
| P/E Ratio | 53.21x |
| P/B Ratio | 5.74x |
| ROE | 6.48% |
| ROCE | 8.43% |
| EPS | Rs 16.22 |
| Book Value Per Share | Rs 150.44 |
| Dividend Yield | 0% |
Sakar Healthcare Ltd. (SAKAR) fundamental metrics show P/E 53.21x, P/B 5.74x, ROE 6.48%, ROCE 8.43%. These figures provide context only and are not a buy or sell signal.
Sakar Healthcare Ltd. has a market capitalisation of Rs 1948.42 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 53.21x, P/B at 5.74x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 6.48% and ROCE of 8.43%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 16.22, book value per share of Rs 150.44, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.92x, median ROE of 11.81%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 53.21x |
| Benchmark Median P/E | 30.92x |
| Benchmark Average P/E | 48.02x |
| Benchmark P/E Range | 3.87x to 667.16x |
| Company P/B Ratio | 5.74x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 6.48% |
| Benchmark Median ROE | 11.81% |
| Company ROCE | 8.43% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 1,948.42 crore |
| Benchmark Median Market Cap | Rs 683.05 crore |
Sakar Healthcare Ltd. (SAKAR) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Sakar Healthcare Ltd. (SAKAR) has a P/E ratio of 53.21x, which is above the benchmark median of 30.92x, a difference of +72.09%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Sakar Healthcare Ltd. (SAKAR) has a ROE of 6.48%, which is below the benchmark median of 11.81%, a difference of -45.13%. Sakar Healthcare Ltd. (SAKAR) has a ROCE of 8.43%, which is below the benchmark median of 13.65%, a difference of -38.24%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,60,696.31 | 38.8 | 5.43 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,46,062.83 | 83.91 | 13.89 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,91,515.22 | 86.82 | 21.1 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,18,403.7 | 25.69 | 4.3 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,14,554.33 | 33.94 | 3.25 | 11.83 | 16 |
Sakar Healthcare Ltd. (SAKAR) has a P/E ratio of 53.21x compared with the displayed peer median of 38.8x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 6.48% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 8.43% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Sakar Healthcare Ltd. (SAKAR) has a market capitalisation of Rs 1,948.42 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Sakar Healthcare Ltd.
- The stock gained 9.11% today, rising from Rs 863.35 to Rs 942.
- It traded near the day’s high of Rs 949 after opening at Rs 866.3.
- Turnover of Rs 16.62 crore indicates notable market participation.
- P/E of 53.21 and P/B of 5.74 are above same-industry medians.
- ROE of 6.48 and ROCE of 8.43 are below same-industry medians.
About Sakar Healthcare Ltd.
Sakar Healthcare Ltd. is a Healthcare company in the Pharmaceuticals & Drugs industry. Based on the supplied data, the stock currently stands out because of a sharp one-day rise combined with valuation multiples above industry medians and profitability ratios below those medians.
Track Sakar Healthcare Ltd. Share Price on Univest
Use Sakar Healthcare Ltd. (SAKAR) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Sakar Healthcare Ltd. (SAKAR) live share-price updates on Univest, along with the top gainers screener and market blogs. These pages help users review live price movement, market cap, valuation ratios, and broader sector context in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Sakar Healthcare Ltd. Share Price rising today?
Ans. Sakar Healthcare Ltd. Share Price rose 9.11% today to Rs 942 from Rs 863.35. The supplied data confirms the move but does not identify a company-specific catalyst. The previous close was Rs 863.35.
What is Sakar Healthcare Ltd. Share Price today?
Ans. The stock is at Rs 942. It opened at Rs 866.3, touched Rs 949, fell as low as Rs 864, and gained Rs 78.65 in the session. The previous close was Rs 863.35.
How does Sakar Healthcare Ltd. compare with industry valuation and profitability levels?
Ans. Its P/E of 53.21 is above the same-industry median of 30.92, and its P/B of 5.74 is above the median of 2.88. Its ROE of 6.48 and ROCE of 8.43 are below the industry medians of 11.81 and 13.65.
How does Sakar Healthcare Ltd. compare with major pharma peers?
Ans. Sakar is much smaller by market cap than Sun Pharma, Divi’s, Torrent, Zydus, and Cipla. Its P/E is above Sun Pharma, Zydus, and Cipla but below Divi’s and Torrent, while its ROE and ROCE are below all five displayed peers.
Recent Articles

Bodal Chemicals Ltd. (BODALCHEM) Share Price Rises 9.21% Today; Key Levels, Valuation and Peer View
1 September 2026

Schneider Electric Infrastructure (SCHNEIDER) Share Price Falls 2.41% Today
1 September 2026

IZMO Ltd. (IZMO): IZMO Share Price Rises 9.99% Today; What the Move Signals
1 September 2026

Indo Count Industries (ICIL) Share Price Falls 5.38% to Rs 444
1 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Bodal Chemicals Ltd. (BODALCHEM) Share Price Rises 9.21% Today; Key Levels, Valuation and Peer View
Schneider Electric Infrastructure (SCHNEIDER) Share Price Falls 2.41% Today
IZMO Ltd. (IZMO): IZMO Share Price Rises 9.99% Today; What the Move Signals
Indo Count Industries (ICIL) Share Price Falls 5.38% to Rs 444
Cords Cable Industries Ltd. (CORDSCABLE): Cords Cable Industries Share Price Rises 10.3% to Rs 312.05
Popular this week
IOL Chemicals And Pharmaceuticals Ltd. (IOLCP) Share Price Hits Fresh 52-Week High at Rs 197.15

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





